Phase
II Study of Methylprednisolone and Xylose Absorption in Children with Hypersensitivity
Vasculitis Associated with Connective Tissue Disease
This study
is currently recruiting patients.
Sponsored by
Children's Memorial
Hospital, Chicago
Purpose
OBJECTIVES: I. Assess xylose absorption
and blood levels of neopterin and von Willebrand factor antigen in children with active
hypersensitivity vasculitis associated with connective tissue disease. II. Correlate the
bioavailability and kinetic rate constant of absorption of oral methylprednisolone with
that of xylose. III. Compare the bioavailability and kinetic rate constant of absorption
of oral methylprednisolone during active and quiescent disease in the same child.
Condition
|
Treatment
or Intervention |
Phase |
vasculitis
|
Drug: methylprednisolone
|
Phase II |
Study Type: Treatment
Official Title: Phase II Study of Methylprednisolone and Xylose
Absorption in Children with Hypersensitivity Vasculitis Associated with Connective Tissue
Disease
Further Study Details: PROTOCOL OUTLINE: Following a 12-hour
fast, patients receive oral xylose and 2 hours later, oral methylprednisolone. The
following day, patients receive intravenous methylprednisolone. Pharmacokinetic studies
are performed each day. Patients are re-treated when disease becomes inactive (6-12 months
later). PROJECTED ACCRUAL: 24 patients will be entered over 2 years.
Eligibility
Ages Eligible for Study: 4 Years
- 18 Years Criteria
PROTOCOL ENTRY CRITERIA: --Disease
Characteristics-- Hypersensitivity vasculitis associated with connective tissue disease
Proven by serology or skin, muscle, or kidney biopsy No severe renal involvement
--Prior/Concurrent Therapy-- Not specified --Patient Characteristics-- Age: Over 4
Performance status: Not specified Hematopoietic: Hemoglobin at least 9 g/dL Hepatic: Not
specified Renal: See Disease Characteristics Other: No other disease No critically ill or
unstable children
Location and Contact Information
Illinois
Children's Memorial Hospital,
Chicago, Chicago, Illinois, 60614, United
States; Recruiting
Lauren M. Pachman
312-880-4360
Study chairs or principal investigators
Lauren M. Pachman, Study Chair
Children's Memorial Hospital, Chicago
More Information
Study ID Numbers 199/11924;
NU-465
NLM Identifier NCT00004357
Date study started September 1, 1997
Last Updated April 1, 2000